Hackensack Meridian Health has become the first health system in the country to earn the Joint Commission’s Responsible Use of AI in Healthcare Certification, the New Jersey-based network announced July 29, 2026. The voluntary credential, launched by the Joint Commission in May 2026, is the accrediting body’s first program built specifically to evaluate how hospitals govern artificial intelligence rather than to clear a single algorithm or device.
For Hackensack Meridian, which operates a network of hospitals and outpatient sites across New Jersey, the review process took roughly three weeks, according to reporting on the certification. Rather than testing whether one AI tool works, surveyors examined the health system’s internal machinery for deciding which AI tools to adopt, how to monitor them once deployed, and how to explain their use to patients.
What the certification actually checks
The Joint Commission evaluated Hackensack Meridian across five core domains: governance and oversight for the responsible use of AI, safeguards to protect patient privacy and healthcare data, processes to identify and reduce risk and bias in AI tools, monitoring to ensure AI tools keep performing safely and effectively over time, and staff training and patient-facing transparency about where AI touches their care. That structure treats AI oversight the way hospitals have long treated infection control or medication safety: as an ongoing operational discipline with named owners, audits and documented processes, not a one-time approval.
Why hospitals need this now
Health systems have rapidly adopted AI tools for tasks ranging from ambient clinical documentation to imaging triage to predictive risk scoring, often piloting several tools at once across different departments with little central coordination. That proliferation has outpaced most hospitals’ formal governance structures, leaving compliance officers and chief medical information officers without a standard way to demonstrate, to regulators or the public, that a given tool was vetted, is being watched for bias or drift, and can be explained to the patients it touches. The Joint Commission designed the RUAIH certification to fill that gap, positioning it alongside its existing hospital and disease-specific accreditation programs.
How Hackensack Meridian describes its approach
In its announcement, Hackensack Meridian said it relies on a formal AI governance structure that pairs data security and privacy protections with rigorous evaluation and ongoing monitoring of AI tools to ensure quality, safety and performance. The health system said it also provides role-specific AI training alongside general AI literacy programs for staff and providers, so clinicians can confidently explain to patients how a given AI tool is supporting their care rather than treating it as a black box embedded in the workflow.
The skeptical read
Health policy observers who track hospital accreditation note that a governance certification, however rigorous its five-domain review, does not independently verify that any specific AI tool inside Hackensack Meridian’s walls is accurate, unbiased or clinically effective — it verifies that the system has a process for checking those things itself. Critics of self-attested compliance frameworks in health care have long argued that governance paperwork can lag actual practice on the floor, and that the real test of a program like this is whether it catches a failing algorithm before it causes harm, not whether the paperwork describing the process passes a three-week survey. The Joint Commission’s certification is voluntary, meaning hospitals that decline to pursue it face no penalty, which limits how much the credential can drive change absent broader adoption.
What comes next
The Joint Commission has said it expects other health systems to pursue the RUAIH certification as AI tools become more deeply embedded in day-to-day clinical operations, and Hackensack Meridian’s early adoption gives the accrediting body a marquee case study to point to as it markets the program more broadly. Whether the certification becomes a meaningful market differentiator — something patients or insurers actually ask about — or a niche credential mostly of interest to compliance departments will likely become clearer over the next year, as more systems either seek it out or decide the voluntary process isn’t worth the resources.
